Does Percutaneous Coronary Intervention Improve Survival for Out-Of-Hospital Cardiac Arrest Patients Receiving Extracorporeal Cardiopulmonary Resuscitation?
Toy, J.; Thompson, K.; Bosson, N.; Abolhoda, A.; Fan, E.; Gudzenko, V.; Shavelle, D. M.
Show abstract
Introduction. Extracorporeal cardiopulmonary resuscitation (ECPR) can support patients who fail to respond to standard resuscitation for out-of-hospital cardiac arrest (OHCA) allowing further time for critical interventions and patient recovery. Although the majority of patients with refractory OHCA have coronary artery disease, the role of emergent percutaneous coronary intervention (PCI) is not clear. We evaluated the effect of PCI on survival to hospital discharge (SHD) in a contemporary cohort of patients with OHCA receiving ECPR. Methods. We performed a retrospective study using data from the Extracorporeal Life Support Organization (ELSO) registry. We included patients ?18 years with OHCA due to a presumed cardiac etiology or an initial shockable rhythm who received ECPR from January 2020 to December 2023. Our primary outcome was SHD. We used inverse probability weighted matching to estimate the average treatment effect of PCI on SHD. We also performed a sensitivity analysis of patients most likely to benefit from PCI (witnessed arrest and no return of spontaneous circulation after five minutes of cardiopulmonary resuscitation. Results. Of 1336 OHCA patients receiving ECPR, 1131 were included in the final analysis after exclusions for age (n=31) and presumed non-cardiac or initial non-shockable rhythm (n=174). The median age was 55 years (IQR 44-62) and most patients were male (n=901, 80%). Twenty-one percent (n=243) received PCI; those patients who received PCI were slightly older (58 [IQR 48-63] vs 53 [IQR 42-62]) and more often male (n=212 [87%] vs n=689 [78%]). In the primary analysis, we found no significant difference in SHD for patients who received PCI compared to those who did not receive PCI (-3.56%, 95% CI -10.31 to 3.19; p-value 0.301). In our sensitivity analysis, we also did not find a significant difference in SHD for patients who received PCI compared to those who did not receive PCI (-4.52%, 95% CI -12.42 to 2.46; p-value 0.246). Conclusion. In our registry-based study of refractory OHCA patients receiving ECPR, emergent PCI was not associated with a significant improvement in SHD.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effectiveness of an Impella versus intra-aortic balloon pump in patients who received extracorporeal membrane oxygenation 95%
- Prognostic Value of Patient-Reported Outcomes in Predicting Long-term Mortality after Transcatheter Aortic Valve Replacement (TAVR) 94%
- Relationship of mild to moderate impairment of left ventricular ejection fraction with fatal ventricular arrhythmic events in cardiac sarcoidosis 94%
Similar papers in this journal
- Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial 93%
- Declining Trend of Sudden Cardiac Death in Younger Individuals: A 20–Year Nationwide Study 93%
- Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator 93%
Similar papers in this journal
Similar papers in this journal
- Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest - a propensity score-matched analysis 95%
- The effect of coronary revascularization treatment timing on mortality in patients with stable ischemic heart disease in British Columbia 95%
- Effects of low versus high inspired oxygen fraction on myocardial injury after transcatheter aortic valve implantation: A randomized clinical trial 94%
Similar papers in this journal
- Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials 92%
- Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection 90%
- Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.